Evolent Health
EVH
227 hedge funds and large institutions have $1.19B invested in Evolent Health in 2025 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 82 increasing their positions, 73 reducing their positions, and 53 closing their positions.
229% more call options, than puts
Call options by funds: $5.46M | Put options by funds: $1.66M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
12% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 73
2.89% more ownership
Funds ownership: 105.03% → 107.92% (+2.9%)
5% less funds holding
Funds holding: 240 → 227 (-13)
13% less capital invested
Capital invested by funds: $1.38B → $1.19B (-$184M)
21% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 53
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cadian Capital Management
New York
|
+$56.3M |
| 2 |
Morgan Stanley
New York
|
+$42.5M |
| 3 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$26.9M |
| 4 |
Goldman Sachs
New York
|
+$17.7M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$15.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$40.2M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$27.1M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$23.4M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.8M |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$10.4M |
EVH Hedge Fund Activity: Q1 2025 in Review
227 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q1 2025, worth a combined $1.19B — down 13% from $1.38B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of EVH and 42 opened new positions — a net loss of 11 holders — while 73 trimmed existing stakes and 82 added.
The largest buyer was Cadian Capital Management, adding an estimated $56.3M. The largest seller was RA Capital Management, exiting entirely with an estimated $40.2M sold.
- 227 institutional investors held Evolent Health (EVH) as of Q1 2025, down from 240 in Q4 2024.
- Funds reported $1.19B of Evolent Health stock for Q1 2025, down 13% quarter-over-quarter.
- 42 funds opened new Evolent Health positions in Q1 2025 and 53 closed out, a net change of -11 holders.
- The largest Evolent Health buyer in Q1 2025 was Cadian Capital Management, an estimated $56.3M added.
- The largest Evolent Health seller in Q1 2025 was RA Capital Management, an estimated $40.2M sold.
Based on aggregated 13F filings for Q1 2025.